Close Menu

TMA

The company announced the launch of the new products in the US and Europe as part of a product portfolio it has named Panther Scalable Solutions.

Hologic Introduces Upgrades to Panther MDx System, Touting Scalability, Flexibility

The upgrades include a method to connect Panther systems to create a higher-throughput system that can be configured to different footprints.

While instrument placements in the quarter increased to 41 from 36 a year ago, the firm missed the consensus analysts' estimate on the top and bottom lines. 

Unhappy with the sales of its urine-based molecular test for the prostate cancer biomarker PCA3, Canadian cancer diagnostics firm DiagnoCure is urging Hologic, the test's commercial conduit, to either step up commercialization efforts or relinquish rights to the test back to Diag

Hologic said this week that fiscal first-quarter clinical diagnostics revenues from Gen-Probe, acquired last summer, were up 9 percent over the comparable period last year, but that blood screening revenues contributed by Gen-Probe declined slightly year over year.

Hologic's planned $3.7 billion acquisition of Gen-Probe, announced earlier this week, is expected to create the largest diagnostics company focused on women's health, according to Hologic officials.

According to a recent survey conducted by investment bank Jeffries, US molecular diagnostics labs expressed "stronger than expected" interest in Gen-Probe's recently launched assays for trichomonas and human papillomavirus, as well as "notable enthusiasm" for the upcoming launch of the company's

Roka Bioscience said Friday that it has secured $47.5 million in Series D financing to support the commercialization of its molecular food safety testing platform.

The 2009 Gen-Probe spinoff has exclusive licensing rights to various Gen-Probe nucleic acid-based tests and instrumentation for use in industrial applications.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.